The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $947,402 in first-year total cost, median $316,719.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JRB-A (13)]3
Most frequent institutions
- GENECENTRIX, INC.1
- NEMALIFE INC.1
- VERISIM LIFE, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | AI-assisted behavioral profiling of an invertebrate model to identify new psychedelic therapeutics for stimulant use disorders1R43DA056089-01 | PATEL, DHAVAL SUBHAS | NEMALIFE INC., TX | $318,373 | ZDA1 |
| 2022 | Leveraging AI to discover neuron-targeted anti-addiction drugs1R44DA056091-01 | FULLER, JENNIFER | GENECENTRIX, INC., NY | $316,719 | ZDA1 |
| 2022 | Development of the AI-driven model for anti-SUD drug development based on neuronal plasticity1R43DA056084-01 | MILLER, COURTNEY AVARSHNEY, JYOTIKA | VERISIM LIFE, INC., CA | $312,310 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.